Emerging Markets: finding your way in a Brave New World
March 1, 2010Sales and Marketing Brazil, China, India, Russia, em, emerging markets, sales, sales force effectiveness
Ask almost any pharmaceutical marketer where the future growth lies for the industry, and the answer will be almost certainly …
Kerrita McClaughlyn joins Hill & Knowlton
March 1, 2010Medical Communications Hill & Knowlton, appointment, medical communications
Hill & Knowlton International Belgium has appointed Kerrita McClaughlyn as an account manager in its healthcare communications team. In her …
ICON sees revenues rise in 2009
March 1, 2010Research and Development CRO, ICON
Contract research organisation ICON saw its revenues increase 3% to $888 million last year and says it is “positive, though …
Pfizer’s Kristin Peck gains business development role
March 1, 2010Sales and Marketing Pfizer, appointment, sales and marketing
Kristin Peck has been appointed senior vice president, worldwide business development, strategy and innovation at Pfizer. She succeeds William Ringo …
Alimta recommended as maintenance therapy
March 1, 2010Sales and Marketing Alimta, Cancer, NSCLC, lilly
NICE has recommended Alimta as a maintenance treatment for people with locally advanced or metastatic non-small cell lung cancer. Patients …
Sanofi’s BSI-201 tipped for success in triple negative breast cancer
February 28, 2010Sales and Marketing Cancer, PARP, Sanofi, breast cancer
Sanofi-Aventis’s BSI-201 will garner sales of $1.7 billion in the triple negative breast cancer drug market in 2018, according to …
Failings at Lilly Humalog plant catch FDA’s eye
February 26, 2010Manufacturing and Production Humalog, lilly
Eli Lilly has been sent a warning letter about a production facility in Puerto Rico, which says the company failed …
Zeltia continue strong growth
February 26, 2010Sales and Marketing 2009 financials, PharmaMar, Yondelis, Zeltia
Consolidated revenues at Spanish biopharmaceutical company Zeltia increased by 17% to 123.4 million euros enabling it to halve operating losses. …
Bayer pharma sales overcome European decline
February 26, 2010Sales and Marketing 2009 financials, Bayer, Xarelto
Bayer’s group sales dropped 5% to 31 billion euros in a “difficult year” for the company that saw a drop …
Talking Point: The future for pharmaceutical delivery
February 26, 2010Manufacturing and Production Polar Speed, Talking Point, logistics, supply chain, talking logistics
Will the future for pharmaceutical delivery need to become more exacting and regulated? An ever greater awareness of the need …
Quotient Clinical receives MHRA Supplementary Accreditation
February 26, 2010Research and Development Quotient
This is one of the highest levels of accreditation in Europe and confirms that Quotient Clinical is qualified to perform …
Government ups the ante in dementia research
February 26, 2010Research and Development Alzheimer's, dementia
The government has attempted to ‘up the ante’ in dementia research by convening a ministerial group comprising charities, scientists, research …
Nick Workman joins A La Carte
February 26, 2010Business Services A La Carte, appointment, business services
Life sciences recruitment search consultancy A La Carte has appointed Nick Workman as international director. In his new role he …
Olivia Wilmshurst-Smith joins Woolley Pau
February 26, 2010Medical Communications Woolley Pau, appointment, medical communications
Advertising agency Woolley Pau has appointed Olivia Wilmshurst-Smith as an account executive. She is a keen linguist and recently graduated …
GSK hits back at Avandia safety probe
February 25, 2010Sales and Marketing Avandia, diabetes
GlaxoSmithKline has hit back at allegations from US Senators that its diabetes drug Avandia raises the risk of heart attacks, …
Digital Pharma: Novartis tells cystic fibrosis stories
February 25, 2010Medical Communications Novartis, cystic fibrosis, digi, digi pharma, social media
Novartis has launched a new disease awareness campaign for cystic fibrosis that blurs the lines between fact and fiction. Its …
Avastin study in ovarian cancer meets primary endpoint
February 25, 2010Research and Development Cancer, avastin, ovarian
Preliminary results from a trial of Roche’s Avastin in advanced ovarian cancer suggest that the drug lengthens progression-free survival when …
Sanofi’s breast cancer candidate tipped for future success
February 25, 2010Research and Development, Sales and Marketing BSI-201, Sanofi-Aventis, breast cancer
A Sanofi-Aventis drug currently in phase III has been predicted as a future blockbuster in breast cancer treatment. Sanofi’s BSI-201 …
GSK’s Deidre Connelly named Woman of the Year
February 25, 2010Sales and Marketing GlaxoSmithKline, HBA, appointment, sales and marketing
The Healthcare Businesswomen’s Association has named Deidre Connelly its 2010 Woman of the Year. Connelly is president of North America …
CME Spotlight: Restoring confidence
February 25, 2010Medical Communications CME, CME Spotlight, Eugene Pozniak, ethics
As John Maynard Keynes said: “The long term doesn’t matter very much, because in the long run, we are all …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
